What top creators are saying about Bevacizumab(AVST)
Anti-VEGF drug marketed as Avastin and used off-label for retinal diseases.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Bevacizumab.
Top creators covering Bevacizumab (AVST)
The 1 sources with the most insights about Bevacizumab on Kazuha.
Latest insights about Bevacizumab (AVST)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
Insurance step-therapy requirements may require patients to try Avastin before newer treatments, potentially affecting Kodiak's commercial adoption.
Yesterday
Insurance step-therapy requirements may require patients to try Avastin before newer treatments, potentially affecting Kodiak's commercial adoption.
Discussed alongside Bevacizumab (AVST)
Other assets that creators frequently mention in the same content as Bevacizumab.
Frequently asked
Which podcasters and creators cover Bevacizumab (AVST) the most?
The most active sources covering Bevacizumab (AVST) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Bevacizumab (AVST) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Bevacizumab (AVST) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Bevacizumab (AVST)?
Creators covering Bevacizumab (AVST) most frequently also discuss KOD, KSI-301, VABY, EYLEA, KSI-101. See the "Discussed alongside" section above for full asset pages.